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Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a chronic disease that becomes one of the leading causes of death in the world. The COPD is usually accompanied by comorbidities that impact prognosis and increase patients’ expenses. However, the comorbidities of COPD patients have not yet to be known in Dr. Hasan Sadikin General Hospital, Bandung, Indonesia. This study was aimed to determine the frequency, type and number of comorbidities accompanying COPD. 
Methods: This study was a retrospective, cross-sectional study at the respirology and critical care outpatient clinic of Dr. Hasan Sadikin General Hospital, Bandung, Indonesia in 2012. Data were obtained from medical records of patients diagnosed with COPD and had an obstructive pulmonary function test result. Sampling 
technique in this study was total sampling. Data were classified by age, gender, smoking history and severity of disease and were analyzed to determine the frequency, type and number of comorbidities accompanying COPD.
Results: Thirty eight COPD patients with obstructive pulmonary function test results were analyzed. It consists of 31 males and 7 females with age ranged between 43–82 years and median age of 64 years. Severe obstruction was found in 15 of 38 patients. Comorbidities were found in 26 patients, and 2 patients had up to four comorbidities. The most common comorbidity was hypertension (9 of 38).
Conclusions: The majority of COPD patients had comorbidities and the most frequent comorbidity was hypertension. [AMJ. 2017;4(1):30–5]
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IntroductionChronic obstructive pulmonary disease (COPD) is a chronic disease that is characterized by persistent airway limitation due to chronic 
inflammatory response in airway and lungs caused by hazardous particle or gas.1 Diagnosis of COPD is usually made on the basis of medical history taking, physical examination, and results from pulmonary function test.2Worldwide, the prevalence of COPD is 4–10% of all population.3,4 The World Health Organization (WHO) has ranked COPD as the fourth leading cause of death.5 The prevalence 
of COPD in Asia Pacific is estimated about 6.3% of all population.6
The COPD is mostly accompanied by comorbidities that can impact patients’ prognosis, change the effectiveness of COPD therapy, cause potentially dangerous therapeutic interactions and increase patients’ expenses in treating the disease.2,7-9 The 
definition of comorbidity is the presence of one or more diseases or health conditions in an individual at a given time.10 Comorbidity is different from complication. Comorbidity can occur regardless of COPD, having the same cause(s), or sharing the same risk factors.7,8 It has been shown that 96.4% COPD patients had one or more comorbidities.9 Cardiovascular disease, skeletal muscle dysfunction, metabolic syndrome, osteoporosis, depression and lung cancer are the most common comorbidities in 
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COPD patients.7 The exact mechanism linking COPD and comorbidities is not yet known.11 A study by Barnes11 and Boschetto et al.12 suggested 
systemic inflammation as the linking mechanism. Patients with COPD have a 
peripheral lung inflammation which may ‘spill over’ to systemic circulation and cause an increase of acute-phase proteins (C-reactive protein and serum amyloid A (SAA)) and 
circulating cytokines (interleukin (IL)-1β, IL-
6, IL-18, and tumor necrosis factor (TNF)-α).  Smoking is the most important risk factor of COPD.7 According to WHO, Indonesia is ranked fourth in the total number of smokers in the world, third in total number of men smokers and seventeenth for women smokers.13 According to the national basic health research 2010 (riset kesehatan dasar/Riskesdas 2010), the percentage of population aged >15 years who smoke every day was 28.2%.14 West Java ranked twelfth for the prevalence of smokers in Indonesia.14 Dr. Hasan Sadikin General Hospital is the provincial referral hospital of West Java and it manages a large amount of 
COPD patients. However, the comorbidities of COPD patients in this hospital have not yet to be known. This study aimed to determine the frequency, type and number of comorbidities accompanied in COPD patients. 
MethodsThe study was a retrospective, cross-sectional study carried out in the respirology and critical care outpatient clinic of Dr. Hasan Sadikin General Hospital, Bandung, Indonesia. The total sampling method was done to COPD patients’ medical records at respirology and critical care outpatient clinic of Dr. Hasan Sadikin General Hospital in January–December 2012. Patients with obstructive pulmonary function test results in the medical record were included in this study while patients with no pulmonary function test result or test result stated the pulmonary function 
as ‘restrictive’ or ‘normal’ were excluded. This study was approved by Health Research Ethics Committee of the Faculty of Medicine, 
Adrian Sebastian Suhendro, Prayudi Santoso, Silvita Fitri Riswari, Primal Sudjana: Comorbidities of Chronic Obstructive Pulmonary Disease Patients at Respirology and Critical Care Outpatient Clinic Dr. Hasan Sadikin General Hospital, Bandung, Indonesia









(n=38)Sex   Male 22 9 31   Female 4 3 7Age (median(range)) 64 (43–82) 59 (43–82) 67 (43–77)Age (years old)
   ≤60 13 2 15   61–70  4 6 10   71–80 6 4 10
   ≥81 3 0 3Smoking History   Smokers 8 4 12   Non Smokers 0 0 0   Unknown 18 8 26Severity of Disease      GOLD 1 1 1 2      GOLD 2 10 4 14      GOLD 3 11 4 15      GOLD 4 4 3 7
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Universitas Padjadjaran and Dr. Hasan Sadikin General Hospital, Bandung, Indonesia.
Data were analyzed using Microsoft Office 
Excel 2010. Data were classified by age, gender, smoking history and severity of disease. Severity of disease was determined by using Global Initiative for Chronic Obstructive Lung 
Disease (GOLD) classification.7 Comorbidity 
was defined as other medical conditions occurred in subjects except pulmonary hypertension as a complication of COPD. We described the frequency of comorbidities in COPD cases, as well as the type and number of comorbidities accompanying COPD in each subject.
ResultsThirty eight COPD patients with obstructive pulmonary function test results were analyzed (Table 1). They consist of 31 males and 7 females, with age ranged between 43–82 years and median age of 64 years. Severe obstruction is the most common pulmonary function test results found in subjects (15 subjects). Twelve patients have a history of cigarette smoking while smoking history is unknown in 26 remaining subjects. Of all COPD patients, 26 had at least one comorbidity (Table 2) while two of them have four comorbidities.Comorbidities that frequently occurred among COPD patients were hypertension (9 of 38), coronary artery disease (5 of 38), heart failure (5 of 38), anemia (4 of 38) and benign prostate hyperplasia (3 of 38) (Table 3).
DiscussionThis study found 26 of 38 COPD patients at a referral hospital having comorbidities, lower than the ones that found in family practice obtained from cross-sectional study using data from National Health and Nutrition Examination Survey of USA in 1999–2008 
(96.4%) or a study by Fumagalli et al.15 (94.1%).8,9 Apart from the differences in study location and potential risk factors, our small simple size may explain this difference.This study found more male COPD patients (31 of 38 subjects). This is similar to the national survey which found COPD prevalence in male (5.3%) to be greater than female (1.4%).8 Same results are shown in the studies by Almagro et al.16 (353 of 398 subjects) and Yamasaki et al.4 (462 of 608 subjects). One explanation may be that cigarette smoking as a risk factor of COPD is more common in male than female. According to WHO, 67.4% men and 4.5% women in Indonesia are active smokers.13 Most COPD patients found in our study aged 60 or younger. It is younger than that found by Almagro et al.16 where the COPD patients aged between 70–80 years old. It might be due to the fact that we recruited patients’ medical records at an outpatient while the other study at an inpatient clinic.Despite the age difference, the severity of pulmonary obstruction found in our study is similar to that of the study by Almagro et al.16 at GOLD 3. While a study by Yamasaki et al.4 at the Tottori University Hospital, Japan, had COPD patients with GOLD 1 as the most frequent patients’ severity. Obstruction in 
COPD patient can be caused by ‘small airway 
disease’ such as airway inflammation, airway 
fibrosis, luminal plugs, or increased airway resistance, and parenchymal destruction, such as loss of alveolar attachments or decrease of elastic recoil.7 COPD exacerbation can also affect the severity of illness by decelerating the rate of lung function.7 The type of comorbidities that frequently occurred in this study was hypertension, as corroborated by other studies except a study by Ekstrom et al.17 in Sweden where heart failure is the most common comorbidity.8,9,15,16 contractively, the Swedish National Oxygen Register, as explained in their paper, found a high 
Table 2 Number of Comorbidities Suffered by One Subject
Comorbidity n
COPD only (or ‘none’) 12COPD + 1 or more 26COPD + 2 or more 18COPD + 3 or more 10COPD + 4 2
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sensitivity and specificity for cardiovascular disease but low sensitivity for less serious and less acute condition such as hypertension.17 The exact mechanism linking hypertension and COPD has not yet known. Hypertension in COPD is probably due to smoking and old age as the sharing risk factor.8,12,15 Also, hypertension could happen because of increased arterial stiffness.15 Another study said that arterial stiffness occur frequently in COPD patients 
due to systemic inflammation.10 Furthermore, 
hypertension could happened because of insulin resistance which related with chronic 
systemic inflammation.18 Almagro et al.16 in his study once said that there was a different distribution of comorbidities in male and female COPD patients. In this study, hypertension is commonly found in male subjects. It is contrary to Garcia-Olmos et al.8, Almagro et al.16, and Ekstrom et al.17 study which said that hypertension as the comorbidity of COPD is 




(n= 31) (n=7)Hypertension 8 1 9Coronary Artery Disease 5 0 5Heart Failure 5 0 5Anemia 3 1 4Benign Prostate Hyperplasia 3 0 3Diabetes Mellitus 2 0 2Diabetes Mellitus with Diabetic Neuropathy 2 0 2Hypertensive Heart Disease 2 0 2Inguinal Hernia 2 0 2Pulmonary Tuberculosis 2 0 2Asthma 0 1 1Breast Cancer 0 1 1Bronchiectasis 1 0 1Cirrhosis 1 0 1Community Acquired Pneumonia 0 1 1Dilated Cardiomyopathy 0 1 1Diverticulitis 1 0 1Dyspepsia 1 0 1Epulis Fibromatosa 1 0 1Grave’s Disease with Thyrotoxicosis 1 0 1Hospital-Community Acquired Pneumonia 1 0 1Hemorrhoid 1 0 1Liver Cancer 1 0 1Peptic Ulcer 0 1 1Rectal Cancer 0 1 1Stroke Sequelle 1 0 1Thyroid Heart Disease 1 0 1Vesiculolithiasis 1 0 1
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commonly occurred in female. This might be related to tobacco smoking, as the sharing risk factor of COPD and hypertension, which more frequent in male than female in Indonesia.13 This difference of study result might happen due to different location of study which 
influences different culture and smoking behavior, particularly in female. According to WHO, prevalence of female smoker in developed country (22%) are more than prevalence of female smoker in developing country (9%).Few cases of diabetes mellitus were found in this study (5.26%). In addition, we could not found skeletal muscle dysfunction, osteoporosis, depression, and lung cancer as comorbidities in COPD patients. It is contrary to GOLD publication and Boschetto et al.12 study which said that besides cardiovascular disease, skeletal muscle dysfunction, metabolic syndrome osteoporosis, depression, and lung cancer are the most common comorbidities found in COPD patients.7 This might be happened because COPD patients that came to respirology and critical care outpatient clinic of Dr. Hasan Sadikin General Hospital did not get bone mass density (BMD) test as osteoporosis marker and mental health detection to screen depression. Patients with lung cancer may found in inpatient instead of outpatient facilities.This study constraint is time and resources, the lack of information found in medical records, which resulted in several missing characteristics data. Furthermore, the onset of comorbidity in COPD patients is unknownIn conclusions, our study revealed high frequency of comorbidities in COPD patients and gives information that hypertension, coronary artery disease, and heart failure were the most frequent comorbidities which are found in COPD patients admitted to respirology and critical care outpatient clinic of Dr. Hasan Sadikin General Hospital in 2012. In addition, due to the comorbidity which often occurs on the COPD patients, it is suggested that physician examine the comorbidity, primarily the most often occurred one, such as hypertension, coronary artery disease, and heart failure, to enhance the quality of health services.
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